---
title: "Download: 'COVID-19's Impact on Virtual Tech in Clinical Trials'"
description: This report delves into the plans of clinical operations leaders to help you understand where to prioritize - and to invest - in virtual tech post-COVID.
image: https://www.info.archemedx.com/hubfs/report_promo_sample%20(1).jpg
---

[![ArcheMedX Logo - Email Template-1](https://www.info.archemedx.com/hs-fs/hubfs/ArcheMedX%20Logo%20-%20Email%20Template-1.png?width=250&height=70&name=ArcheMedX%20Logo%20-%20Email%20Template-1.png "ArcheMedX Logo - Email Template-1")](https://www.archemedx.com/)

# **Find out what your peers, partners, and competitors are doing with virtual tech** **when you download the report on** ***COVID-19's Impact on Virtual Tech in Clinical Trials.***

 

![Screen Shot 2020-09-01 at 4.01.19 PM](https://www.info.archemedx.com/hubfs/Screen%20Shot%202020-09-01%20at%204.01.19%20PM.png "Screen Shot 2020-09-01 at 4.01.19 PM")

 

 

 

 

## How Will the Life Sciences Industry Use Virtual Tech in Clinical Trials post-COVID?

Six months after COVID-19 hit, one trend has emerged as a dominant theme: **overhauling the very manual and expensive study start up with virtual tech**. 

In this report, you’ll discover:

- Where clinical operations leaders are planning to adopt virtual technology.
- The new, post-COVID priorities for pharma and biotech leaders.
- Where you should be investing in virtual tech so you aren't left behind.

 

### Copyright ©2026 ArcheMedX, Inc. All rights reserved.